BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Biologics

Akeso’s Ivonescimab Shows Significant Overall Survival Benefit Over Pembrolizumab in Phase III NSCLC Trial

Akeso, Inc. announced that a pre-specified interim analysis of overall survival (OS) in the HARMONi-2 (AK112-303) trial, as assessed by the Independent Dat...

September 04, 2026 | News

Norroy Bioscience Secures China Clearance for Phase III Trial of PSMA-Targeted Radiopharmaceutical

NORROY BIOSCIENCE (NORROY), a clinical-stage biotechnology company focused on innovative targeted radiopharmaceuticals, announced that it has received regu...

September 04, 2026 | News

Alteogen, Novartis Ink Up to $3.2B Deal for Subcutaneous Biologics Using ALT-B4

Novartis obtains rights to develop and commercialize subcutaneous formulations for multiple products utilizing ALT-B4 Alteogen's fourth licensing agreem...

September 04, 2026 | News

EpiVax Adds AI-Enabled Enhancements to ISPRI Immunogenicity Risk Platform

EpiVax, Inc. is pleased to announce the release of AI-enabled enhancements to ISPRI™, its proprietary in silico platform for assessing the ...

September 04, 2026 | News

Food, Drug, or Neither

Yesterday was the deadline. Japan's Consumer Affairs Agency has stated that the revised labelling provisions and mandatory Good Manufacturing Practice sta...

September 03, 2026 | Analysis

Genprex Selects Andelyn Biosciences to Scale Up AAV Gene Therapy for Diabetes

Andelyn Biosciences, a leading contract development and manufacturing organization, announced that Genprex, Inc. has selected Andelyn to support scale-up m...

September 03, 2026 | News

IDT and Ansa Expand Global Access to Complex DNA Synthesis Through Integrated Ordering

Streamlined workflow provides earlier visibility into synthesis feasibility, pricing, and fulfillment options Global adoption growing with more than 400...

September 03, 2026 | News

Cartherics Explores Tissue Factor-Targeting CAR-NK Therapies for Cancer and Endometriosis

Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company developing off-the-shelf immu...

September 03, 2026 | News

US FDA Grants Fast Track Designation to T-MAXIMUM’s Allogeneic CAR-T Therapy for Recurrent Glioblastoma

T-MAXIMUM PHARMACEUTICAL Inc. ("T-MAXIMUM") announced that its investigational allogeneic CAR-T cell therapy MT027 has been granted Fast Track Designation ...

September 02, 2026 | News

Astellas Reaches US Government Agreement to Lower Medicaid Drug Prices, Strengthen Medicine Supply Chain

Agreement supports commitment to patient access, affordability and innovation – Astellas Pharma Inc. announced that it has reached an agreemen...

September 02, 2026 | News

DualityBio, Genentech Ink $1B-Plus Deal to Develop Next-Generation ADCs Against Drug-Resistant Tumours

Collaboration leverages DualityBio's proprietary DUPAC payload platform and early global clinical development capabilities, with Genentech assuming furth...

August 31, 2026 | News

Formosa Pharmaceuticals Files European CTA for TSY-110, Potential First Kadcyla Biosimilar in Regulated Markets

TSY-110 is positioned to become the first biosimilar alternative to Roche's Kadcyla® (ado-trastuzumab emtansine) in major regulated markets. -- F...

August 31, 2026 | News

Thermo Fisher Launches EMPAD G2 Detector to Advance High-Speed 4D STEM Imaging

Thermo Fisher Scientific Inc., the world leader in serving science, introduced the Thermo Scientific™ EMPAD™ G2 detector, a new detector design...

August 28, 2026 | News

PENTAX Medical, MAGENTIQ EYE Expand AI-Assisted Colonoscopy Partnership Globally

Expanded agreement combines PENTAX Medical's continued investment in flexible reusable endoscopy with MAGENTIQ's clinically validated AI capabilities, expa...

August 28, 2026 | News

Stay Connected